-
1 Comment
Ramsay Health Care Limited is currently in a long term uptrend where the price is trading 1.0% above its 200 day moving average.
From a valuation standpoint, the stock is 100.0% cheaper than other stocks from the Healthcare sector with a price to sales ratio of 0.0.
Ramsay Health Care Limited's total revenue sank by 0.1% to $6B since the same quarter in the previous year.
Its net income has dropped by 12.5% to $226M since the same quarter in the previous year.
Finally, its free cash flow grew by 1305.4% to $365M since the same quarter in the previous year.
Based on the above factors, Ramsay Health Care Limited gets an overall score of 3/5.
ISIN | AU0000RHCPA4 |
---|---|
Sector | Healthcare |
Industry | Medical Care Facilities |
CurrencyCode | AUD |
Exchange | AU |
Target Price | None |
---|---|
Beta | 0.56 |
Dividend Yield | 5.7% |
PE Ratio | 0.0 |
Market Cap | 16B |
Ramsay Health Care Limited owns and operates hospitals. The company also offers health care services to public and private patients. It operates facilities in approximately 532 locations in the Asia Pacific, the United Kingdom, France, and Nordics. The company was founded in 1964 and is based in Sydney, Australia.
Learn MoreHere's how to backtest a trading strategy or backtest a portfolio for RHCPA.AU using our backtest tool. PyInvesting provides the backtesting software for you to backtest your investment strategy. Our backtest software is written using Python code and allows you to backtest stock, backtest etf, backtest options, backtest crypto and backtest forex online. Our backtesting Python framework is highly robust and gives you a realistic simulation of how your strategy would have performed in the past using backtest data.
© PyInvesting 2024